Skip to main content
Sign In

You have reached the Web site for the Department of Pathology at the University of Colorado Denver.

Pathology Banner Image
 

Bradford J. Siegele, MD, JD

PGY III


Education:​

 – 

 – 

 – 

 – 

BA, English & Philosophy; Duke University, Durham, North Carolina (1999)

JD; Harvard Law School, Cambridge, Massachusetts (2005)

Research Fellow; National Institutes of Health, Bethesda, Maryland (2010-2011)

MD; University of Texas Southwestern Medical Center at Dallas Southwestern Medical School, Dallas, Texas (2012)

 ​

Research Interests:​

 – 

 – 

 – 

 – 

Use of gene therapy techniques to target genetically-defined diseases

Whole genome sequencing

Pediatric Pathology

Neuropathology

 

Selected Publications:

 – 

 

 

 – 

 

 

 – 

 

 

 

Siegele B, Cefalu C, Holm NT, Sun G, Tubbs J, Meschonat C, Odaka Y, DeBenedetti A, Chali GE, Chu QD, Mathis JM, Li BD. elF4E-targeted suicide gene therapy in a minimal residual mouse model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free survival. J Surg Res. 2008 Jul; 148(1):83-89.

Patel V, Iglesias-Bartolome R, Siegele B, Marsh CA, Leelahavanichkul K, Molinolo AA, Gutkind JS. Advances in Experimental Medicine and Biology: Human Cell Transformation. In Rihm and Kremer (Ed.), Cellular Systems for Studying Human Oral Squamous Cell Carcinomas (pp. Chapter 3). New York, NY: Springer (2011).

Siegele B, Cefalu C, Holm N, Sun G, Chu QD, Tubbs J, Meschonat C, Odaka Y, Mathis JM, Ghali GE, Li BD. Translation Initiation Factor elF4E-targeted Suicide Gene Therapy Following Cytoreductive Surgery Improves Disease Free Survival In A Mouse Soft Tissue Metastasis Model For Head and Neck Squamous Cell Carcinoma. Poster presented at Ray A. Barlow Scientific Symposium, Shreveport, LA (2008).

 

Contacts:

 Email:

 Pager:

Bradford.Siegele@ucdenver.edu

(303) 266-4041

​​